Glanbia's stock prices soar 15% following the positive revenue forecast update
In a significant development, Irish nutrition and ingredients giant Glanbia has announced the sale of its underperforming Body & Fit unit. The company, known for its top-selling brand Optimum Nutrition, also sold its Dutch ecommerce platform Body&Fit for an undisclosed sum.
Despite these moves, Glanbia's CEO, Hugh McGuire, reported a 6% revenue growth in the first half of the year, with the total revenue reaching $1.9 billion. The performance nutrition division, a star performer in recent years, has been a key driver of this growth.
However, the company faced challenges in other areas. In February, Glanbia issued a profit warning linked to higher-than-expected whey prices. This was followed by a non-cash impairment charge of $91 million last year relating to falling sales at the SlimFast business unit. As of now, there is no news on the planned sale of Glanbia's underperforming dieting brand SlimFast.
In a bid to streamline operations, Glanbia restructured in July 2025 by establishing its US dairy business as a stand-alone division with its own management. This move is aimed at improving focus across its segments, including Health & Nutrition, Performance Nutrition, and Dairy Nutrition. CEO Hugh McGuire clarified that this new structure is not intended to facilitate a sale of the dairy division.
There has been some market speculation that Glanbia might seek to offload its dairy division to focus more on sports nutrition and ingredients segments. However, these rumours have not been confirmed by the company, and McGuire explicitly stated that the company's current strategy involves growth and investment in both dairy and nutrition segments, not divestment of dairy.
Goodbody analyst Patrick Higgins noted the incremental stabilization of demand behind the core performance nutrition portfolio and confidence in managing margins despite elevated whey costs. In light of these strong results, Glanbia upgraded its full-year earnings guidance to 130-133 cent per share.
In other news, Glanbia appointed Paul Duffy as chairman designate, replacing Donal Gaynor at the end of the year. The company also acquired Sweetmix, a Brazil-based nutritional solutions business, to strengthen its Health & Nutrition division globally.
Glanbia's shares jumped by approximately 16% on Wednesday, following the upgraded earnings guidance. The upgrade resulted in Glanbia's shares rising by 15.8% to €14.12 in Dublin.
As of August 2025, Glanbia has not announced any plans to sell its dairy division. The company's focus remains on growth and investment in both its dairy and nutrition segments.
[1] Glanbia's Q2 results showcase growth in health and nutrition divisions, despite challenges in performance nutrition: [Link to Source]
[2] Glanbia restructures US dairy business, denies plans to sell dairy division: [Link to Source]
[3] Glanbia acquires Sweetmix, a Brazil-based nutritional solutions business: [Link to Source]
[4] Market speculation suggests Glanbia may offload dairy division: [Link to Source]
Read also:
- A Business Model Explained: Its Purpose and Benefits for Your Venture
- Deep-rooted reinforcement of Walkerhughes' acquisitions through strategic appointment of Alison Heitzman
- Unchecked Management of HP Dams Leads to Environmental Disaster: RTI Reveals
- Impact of Trump's Enforced Russia Sanctions Could Compel Putin's Decision-Making
